Yan Lou

Yan Lou has worked in the biopharmaceutical industry for over 17 years. Yan began their career in 2002 as a Postdoc at Harvard University. Yan then moved to Roche in 2005, where they worked as a Principal Scientist for seven years. In 2012, they joined Novartis as an Investigator III. In 2014, they became an Associate Director at Nurix Inc. and then a Director at Principia Biopharma in 2015. In 2017, they became Chief Discovery Officer at NiKang Therapeutics and in 2019 they were promoted to Chief Scientific Officer at NiKang Therapeutics Inc.

Yan Lou received a Bachelor degree from the University of Science and Technology of China in 1998, and a PhD from Dartmouth College in 2002.